Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.08 - Poster Session 1 - Radiotherapy
- Type: Poster Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 27
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.08-025 - How to Determine Internal Margin for Clinical Practice? - A Study of 44 Lung Cancer cases with 4D-CT Imaging.
09:30 - 09:30 | Author(s): M. Chen
- Abstract
Loading...
-
+
P1.09 - Poster Session 1 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.09-022 - A Multicenter, Randomized, Open-label, Phase II Trial of Erlotinibversus Etoposideplus Cisplatinwith Concurrent Radiotherapy in UnresectableStage III Non-smallCell Lung Cancer (NSCLC) with Activating Mutation of Epidermal Growth Factor Receptor (EGFR) in Exon 19 or 21(RECEL, ML28545, NCT01714908)
09:30 - 09:30 | Author(s): L. Xing
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-021 - First-line erlotinib versus cisplatin/gemcitabine (GP) in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC): interim analyses from the phase 3, open-label, ENSURE study
09:30 - 09:30 | Author(s): Y. Wu
- Abstract
Loading...
-
+
P1.13 - Poster Session 1 - SCLC
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 8
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.13-008 - Omitting elective nodal irradiation and irradiating post-induction versus pre-induction chemotherapy tumor extent for limited-stage small cell lung cancer: an update of a prospective randomized trial
09:30 - 09:30 | Author(s): M. Chen
- Abstract
Loading...
-
+
P2.08 - Poster Session 2 - Radiotherapy
- Type: Poster Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.08-003 - Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study
09:30 - 09:30 | Author(s): H.L. Ma
- Abstract
Loading...
-
+
P2.24 - Poster Session 2 - Supportive Care
- Type: Poster Session
- Track: Supportive Care
- Presentations: 61
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.24-031 - Pre-treatment symptom profiles predict survival in patients with non-small cell lung cancer
09:30 - 09:30 | Author(s): M. Chen
- Abstract
Loading...
-
+
P3.08 - Poster Session 3 - Radiotherapy
- Type: Poster Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 28
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.08-025 - Lung Tumors with Big Size or Irregular Shape or High-mobility can Better Benefit from Four-dimensional Radiotherapy
09:30 - 09:30 | Author(s): M. Chen
- Abstract
Loading... -
+
P3.08-028 - Impact of dosevolume parameters and clinical factors on severe acute radiation pneumonitis for lung cancer patients treated with concurrent chemo-radiotherapy
09:30 - 09:30 | Author(s): J. Wang
- Abstract
Loading...
-
+
MO25 - NSCLC - Combined Modality Therapy II
- Type: Mini Oral Abstract Session
- Track: Mesothelioma
- Presentations: 11
- Moderators:T. Le Chevalier
- Coordinates: 10/30/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
MO25.04 - Phase II study comparing Cisplatin/Etoposide and weekly Paclitaxol/Carboplatin regimens with concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
10:45 - 10:50 | Author(s): J. Liang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.06 - Phase I/II trial of recombinant human endostatin in combination with concurrent chemo-radiotherapy in the patients with stage III non-small-cell lung cancer
11:05 - 11:10 | Author(s): M. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
